| Warfarin Teva 10 mg tablets PA2050/001/009 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 2 mg tablets PA2050/001/003 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 2.5 mg tablets PA2050/001/004 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 3 mg tablets PA2050/001/005 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 5 mg tablets PA2050/001/006 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 6 mg tablets PA2050/001/007 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Warfarin Teva 7.5 mg tablets PA2050/001/008 |
Warfarin sodium clathrate |
Sun Pharmaceutical Industries Europe B.V. |
Marketed |
| Water for Injections Ph Eur PA1122/001/001 |
Water for injections |
Noridem Enterprises Limited |
Marketed |
| Water for Injections Ph. Eur PA0179/009/003 |
Water for injections |
B. Braun Medical Limited, |
Marketed |
| Water for Injections Ph. Eur., viaflo container PA2299/013/001 |
Water for injection |
Baxter Holding B.V. |
Marketed |
| Water for injections, solvent for parenteral use PA2059/035/001 |
Water for injections |
Fresenius Kabi Deutschland GmbH |
Marketed |
| Waylivra 285 mg Solution for injection EU/1/19/1360/001-002 |
VOLANESORSEN SODIUM |
Akcea Therapeutics Ireland Ltd |
— |
| WAYRILZ 400 mg film-coated tablets EU/1/25/1974/001-003 |
Rilzabrutinib |
Sanofi B.V. |
— |
| Wegovy 0.25 mg Solution for injection EU/1/21/1608/001 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 0.25 mg Solution for injection EU/1/21/1608/006 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 0.5 mg Solution for injection EU/1/21/1608/002 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 0.5 mg Solution for injection EU/1/21/1608/007/012 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 1 mg Solution for injection EU/1/21/1608/003 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 1 mg Solution for injection EU/1/21/1608/008 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 1.7 mg Solution for injection EU/1/21/1608/004 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 1.7 mg Solution for injection EU/1/21/1608/009 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 2.4 mg Solution for injection EU/1/21/1608/005 |
Semaglutide |
Novo Nordisk A/S |
— |
| Wegovy 2.4 mg Solution for injection EU/1/21/1608/010-011 |
Semaglutide |
Novo Nordisk A/S |
— |
| WELIREG 40 mg film-coated tablets EU/1/24/1893/001-002 |
Belzutifan |
Merck Sharp & Dohme BV, |
— |
| WEZENLA 130 mg Concentrate for solution for infusion EU/1/24/1823/004 |
Ustekinumab |
Amgen Technology (Ireland) UC |
— |
| WEZENLA 45 mg Solution for injection EU/1/24/1823/001 |
Ustekinumab |
Amgen Technology (Ireland) UC |
— |
| WEZENLA 45 mg Solution for injection pre-filled syringe EU/1/24/1823/002 |
Ustekinumab |
Amgen Technology (Ireland) UC |
— |
| WEZENLA 90 mg Solution for injection pre-filled syringe EU/1/24/1823/003 |
Ustekinumab |
Amgen Technology (Ireland) UC |
— |
| WILZIN EU/1/04/286/1-2 |
Zinc acetate dihydrate |
Recordati Rare Diseases |
— |
| Winlevi 10 mg/g cream EU/1/25/1927/001-003 |
Clascoterone |
Cassiopea S.p.A. |
— |
| Winrevair 45 mg powder and solvent for solution for injection EU/1/24/1850/001-002 |
Sotatercept |
Merck Sharp & Dohme BV, |
— |
| Winrevair 60 mg powder and solvent for solution for injection EU/1/24/1850/003-004 |
Sotatercept |
Merck Sharp & Dohme BV, |
— |
| Wyost 120 mg solution for injection EU/1/24/1812/001 |
Denosumab |
Sandoz GmbH |
— |
| Xadago 100 mg Film-coated tablet EU/1/14/984/006-010 |
Safinamide methanesulfonate |
Zambon S.p.A. |
— |
| Xadago 50 mg Film-coated tablet EU/1/14/984/001-005 |
Safinamide methanesulfonate |
Zambon S.p.A. |
— |
| Xagrid 0.5 mg hard capsules EU/1/04/295/001 |
Anagrelide hydrochloride |
Takeda Pharmaceuticals International AG Ireland Branch |
— |
| XALKORI 20 mg granules in capsules for opening EU/1/12/793/005 |
Crizotinib |
Pfizer Europe MA EEIG |
— |
| XALKORI 200 mg hard capsules EU/1/12/793/001-002 |
Crizotinib |
Pfizer Europe MA EEIG |
— |
| XALKORI 250 mg hard capsules EU/1/12/793/003-004 |
Crizotinib |
Pfizer Europe MA EEIG |
— |
| Xaluprine 20 mg/ml oral suspension EU/1/11/727/001 |
Mercaptopurine monohydrate |
Lipomed GmbH |
— |
| Xarelto 1 mg/ml granules for oral suspension EU/1/08/472/050-051 |
Rivaroxaban |
Bayer AG |
— |
| Xarelto 10 mg film-coated tablets EU/1/08/472/1-8 |
Rivaroxaban |
Bayer AG |
— |
| Xarelto 15 mg film-coated tablets EU/1/08/472/011-016 |
Rivaroxaban |
Bayer AG |
— |
| Xarelto 15 mg film-coated tablets Xarelto 20 mg film-coated tablets EU/1/08/472/040 |
Rivaroxaban, Rivaroxaban |
Bayer AG |
— |
| Xarelto 2.5 mg film-coated tablets EU/1/08/472/025-033 |
Rivaroxaban |
Bayer AG |
— |
| Xarelto 20 mg film-coated tablets EU/1/08/472/017-021 |
Rivaroxaban |
Bayer AG |
— |
| Xbryk 120 mg solution for injection EU/1/24/1889/001-002 |
Denosumab |
Samsung Bioepis NL B.V. |
— |
| Xelevia 100 mg film-coated tablets EU/1/07/382/13-18 |
Sitagliptin phosphate monohydrate |
Merck Sharp & Dohme BV |
— |
| Xelevia 25 mg film-coated tablets EU/1/07/382/1-6 |
Sitagliptin phosphate monohydrate |
Merck Sharp & Dohme BV |
— |
| Xelevia 50 mg film-coated tablets EU/1/07/382/7-12 |
Sitagliptin phosphate monohydrate |
Merck Sharp & Dohme BV |
— |